WHO classification of tumours: pathology and genetics of tumours of endocrine organs: Lyon: IARC, 2017. ,
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma, Cancer Cell, vol.31, issue.2, pp.181-93, 2017. ,
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification, Endocr Rev, vol.38, issue.6, p.5716829, 2017. ,
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma, Science, vol.287, issue.5454, pp.848-51, 2000. ,
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma, Am J Hum Genet, vol.69, issue.1, pp.49-54, 2001. ,
, , p.1226047
Mutations in SDHC cause autosomal dominant paraganglioma, type 3, Nat Genet, vol.26, issue.3, pp.268-70, 2000. ,
SDHA is a tumor suppressor gene causing paraganglioma, Hum Mol Genet, vol.19, issue.15, pp.3011-3031, 2010. ,
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma, Science, vol.325, issue.5944, pp.1139-1181, 2009. ,
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas, Hum Mol Genet, vol.23, issue.9, pp.2440-2446, 2013. ,
Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene, Journal of the National Cancer Institute, vol.107, issue.5, 2015. ,
The evolving role of succinate in tumor metabolism: an 18F-FDG-based study, J Nucl Med, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01770170
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction, J Natl Cancer Inst, vol.105, issue.17, pp.1270-83, 2013. ,
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma, Cancer cell, vol.23, issue.6, pp.739-52, 2013. ,
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes, J Clin Endocrinol Metab, vol.91, issue.3, pp.827-863, 2006. ,
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography, J Natl Cancer Inst, vol.104, issue.9, pp.700-708, 2012. ,
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family, BMC Med Genet, vol.11, p.2891715, 2010. ,
Are we overestimating the penetrance of mutations in SDHB?, Hum Mutat, vol.31, issue.6, pp.761-763, 2010. ,
Penetrance and clinical consequences of a gross SDHB deletion in a large family, Clin Genet, vol.75, issue.4, pp.354-63, 2009. ,
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers, Clin Genet, 2017. ,
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD, J Med Genet, 2018. ,
Cost-effectiveness of androgen suppression therapies in advanced prostate cancer, J Natl Cancer Inst, vol.92, issue.21, pp.1731-1740, 2000. ,
Markov models of breast tumor progression: some age-specific results, J Natl Cancer Inst Monogr, vol.22, pp.93-100, 1997. ,
Survival outcomes after contralateral prophylactic mastectomy: a decision analysis, J Natl Cancer Inst, vol.106, issue.8, 2014. ,
PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data, Genome Res, vol.17, issue.11, pp.1665-74, 2007. ,
, , p.2045149
Models of parent-of-origin tumorigenesis in hereditary paraganglioma, Semin Cell Dev Biol, vol.43, pp.117-141, 2015. ,
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer, Cancer Cell, vol.8, issue.2, pp.155-67, 2005. ,
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas, Oncotarget, vol.8, issue.9, p.5362423, 2017. ,
Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas, World J Surg, vol.38, issue.3, p.24322175, 2014. ,
Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis, Clin Cancer Res, vol.21, issue.19, pp.4451-60, 2015. ,
Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance, Cancer Res, vol.68, issue.13, p.4191850, 2008. ,